ClinicalTrials.Veeva

Menu

The Role of Endogenous GLP-1 (Glycolipoprotein) in Regulating Glucose Stimulated Brain Activity

University Hospital Basel logo

University Hospital Basel

Status

Completed

Conditions

Exploratory Behavior

Treatments

Dietary Supplement: 75g glucose in 300ml tap water with 600pmol/kg/min exendin 9-39
Dietary Supplement: 25g Fructose in 300ml tap water
Dietary Supplement: Single intragastric instillation of 75g Glucose in 300ml tap water with 450ppm lactisole
Dietary Supplement: 300ml tap water with 450ppm lactisole
Dietary Supplement: Single intragastric instillation of 75g Glucose in 300ml tap water via nasogastric tube
Dietary Supplement: tap water

Study type

Interventional

Funder types

Other

Identifiers

NCT01918566
EKBB 298/12

Details and patient eligibility

About

Our objective is to investigate neuro-anatomical correlates of the regulation of energy intake by means of functional MRI. Administration of glucose with and without lactisole and exendin as well as fructose is followed by functional brain MRI, and findings are correlated with serum GLP-1 levels as an endogenous satiety signal in humans.

Enrollment

12 patients

Sex

Male

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • right-handed healthy males, no drugs, non-smoking

Exclusion criteria

  • drug abuse, smoker, left-handed, claustrophobia

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

12 participants in 6 patient groups, including a placebo group

300ml tap water
Placebo Comparator group
Description:
Single intragastric instillation of 300ml tap water via nasogastric tube
Treatment:
Dietary Supplement: tap water
Glucose
Active Comparator group
Description:
Single intragastric instillation of 75g Glucose in 300ml tap water via nasogastric tube
Treatment:
Dietary Supplement: Single intragastric instillation of 75g Glucose in 300ml tap water via nasogastric tube
Glucose plus Lactisole
Active Comparator group
Description:
Single intragastric instillation of 75g Glucose in 300ml tap water with 450ppm lactisole
Treatment:
Dietary Supplement: Single intragastric instillation of 75g Glucose in 300ml tap water with 450ppm lactisole
Fructose
Active Comparator group
Description:
Single intragastric instillation of 25g Fructose in 300ml tap water via nasogastric tube
Treatment:
Dietary Supplement: 25g Fructose in 300ml tap water
Glucose and Exendin
Active Comparator group
Description:
Single intragastric instillation of 75g glucose in 300ml tap water with 600pmol/kg/min exendin 9-39
Treatment:
Dietary Supplement: 75g glucose in 300ml tap water with 600pmol/kg/min exendin 9-39
tap water, lactisole
Sham Comparator group
Description:
Single intragastric instillation of 300ml tap water with 450ppm lactisole
Treatment:
Dietary Supplement: 300ml tap water with 450ppm lactisole

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems